Materials Metric: Pre-clinical CRO | Research & Development Services & Support Organization

Biocompatibility Assessment Services

At Materials Metric, we provide comprehensive biocompatibility assessment services to evaluate the safety and compatibility of materials intended for medical, pharmaceutical, and biomedical applications. These tests ensure that materials do not cause harmful biological reactions when in contact with living tissues, making them crucial for medical devices, implants, and drug formulations.

Biocompatibility Assessment Services

In-vitro Cell-Based Assays

In-vitro cell-based assays are laboratory tests that analyze how materials interact with living cells in a controlled environment. These tests help assess cytotoxicity, cell viability, and biological responses before in-vivo studies.

Capabilities:

  • Cell viability and proliferation studies

  • Assessment of material-induced inflammation or apoptosis

  • Functional assays for biomaterial performance

In-vivo Studies

In-vivo studies involve testing materials or medical devices in live animal models to assess their safety, functionality, and long-term biological effects. These tests provide critical insights into systemic toxicity, immune response, and tissue integration.

Capabilities:

  • Biodegradation and bioresorption analysis

  • Tissue response and inflammation evaluation

  • Long-term performance assessment under physiological conditions

Biocompatibility Assessment Services
Biocompatibility Assessment Services

Cytotoxicity and Systemic Toxicity Testing

Assessing toxic effects of materials on biological systems

Capabilities:

  • Evaluates whether a material damages or kills cells

  • Uses standard assays like MTT, LDH, and Trypan Blue exclusion

  • Essential for compliance with ISO 10993-5 for medical device testing

Extractables and Leachables (E&L) Testing

Ensuring materials do not release harmful substances

Extractables and Leachables (E&L) testing identifies potentially hazardous chemicals that may be released from materials under different conditions, ensuring product safety.

Capabilities:

  • Identification of organic and inorganic extractables using GC-MS, LC-MS, and ICP-MS

  • Simulated-use conditions to detect leachable contaminants

  • Compliance with USP <1663> and <1664>, ISO 10993-18, and FDA guidelines

Biocompatibility Assessment Services
Scroll to Top